Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 20 of 20 Results Clear All
Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure
Haldar Lab Srivastava Lab Stem Cells/iPSCs Heart Failure
A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.
Heart Failure Congenital Heart Disease Bruneau Lab Haldar Lab Srivastava Lab Basic Science
Research on a gene mutation that causes holes in the hearts of infants revealed insights into how the heart develops and how it stays healthy.
Heart Failure Congenital Heart Disease Srivastava Lab
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
Heart Failure
Yen-Sin Ang, PhD, a research scientist at the Gladstone Institutes, was awarded the Louis N. and Arnold M. Katz Basic Research Prize, the most prominent young investigator award bestowed by the American Heart Association.
Heart Failure Congenital Heart Disease Srivastava Lab
